Global Gene-based Therapy Medicinal Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Gene-based Therapy Medicinal market size was valued at USD 9325.9 million in 2022 and is forecast to a readjusted size of USD 44180 million by 2029 with a CAGR of 24.9% during review period.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
The Global Info Research report includes an overview of the development of the Gene-based Therapy Medicinal industry chain, the market status of Neurological Diseases (Viral Gene Delivery System, Non-viral Gene Delivery System), Cancer (Viral Gene Delivery System, Non-viral Gene Delivery System), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene-based Therapy Medicinal.
Regionally, the report analyzes the Gene-based Therapy Medicinal markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene-based Therapy Medicinal market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene-based Therapy Medicinal market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene-based Therapy Medicinal industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene-based Therapy Medicinal market.
Regional Analysis: The report involves examining the Gene-based Therapy Medicinal market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene-based Therapy Medicinal market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene-based Therapy Medicinal:
Company Analysis: Report covers individual Gene-based Therapy Medicinal players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene-based Therapy Medicinal This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neurological Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Gene-based Therapy Medicinal. It assesses the current state, advancements, and potential future developments in Gene-based Therapy Medicinal areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene-based Therapy Medicinal market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene-based Therapy Medicinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Gene-based Therapy Medicinal product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene-based Therapy Medicinal, with revenue, gross margin and global market share of Gene-based Therapy Medicinal from 2018 to 2023.
Chapter 3, the Gene-based Therapy Medicinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene-based Therapy Medicinal market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene-based Therapy Medicinal.
Chapter 13, to describe Gene-based Therapy Medicinal research findings and conclusion.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
The Global Info Research report includes an overview of the development of the Gene-based Therapy Medicinal industry chain, the market status of Neurological Diseases (Viral Gene Delivery System, Non-viral Gene Delivery System), Cancer (Viral Gene Delivery System, Non-viral Gene Delivery System), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene-based Therapy Medicinal.
Regionally, the report analyzes the Gene-based Therapy Medicinal markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene-based Therapy Medicinal market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene-based Therapy Medicinal market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene-based Therapy Medicinal industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Delivery System, Non-viral Gene Delivery System).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene-based Therapy Medicinal market.
Regional Analysis: The report involves examining the Gene-based Therapy Medicinal market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene-based Therapy Medicinal market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene-based Therapy Medicinal:
Company Analysis: Report covers individual Gene-based Therapy Medicinal players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene-based Therapy Medicinal This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neurological Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Gene-based Therapy Medicinal. It assesses the current state, advancements, and potential future developments in Gene-based Therapy Medicinal areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene-based Therapy Medicinal market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene-based Therapy Medicinal market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Gene-based Therapy Medicinal product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene-based Therapy Medicinal, with revenue, gross margin and global market share of Gene-based Therapy Medicinal from 2018 to 2023.
Chapter 3, the Gene-based Therapy Medicinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene-based Therapy Medicinal market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene-based Therapy Medicinal.
Chapter 13, to describe Gene-based Therapy Medicinal research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Gene-based Therapy Medicinal
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene-based Therapy Medicinal by Type
1.3.1 Overview: Global Gene-based Therapy Medicinal Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Gene-based Therapy Medicinal Consumption Value Market Share by Type in 2022
1.3.3 Viral Gene Delivery System
1.3.4 Non-viral Gene Delivery System
1.4 Global Gene-based Therapy Medicinal Market by Application
1.4.1 Overview: Global Gene-based Therapy Medicinal Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Neurological Diseases
1.4.3 Cancer
1.4.4 Other
1.5 Global Gene-based Therapy Medicinal Market Size & Forecast
1.6 Global Gene-based Therapy Medicinal Market Size and Forecast by Region
1.6.1 Global Gene-based Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Gene-based Therapy Medicinal Market Size by Region, (2018-2029)
1.6.3 North America Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.4 Europe Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.6 South America Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene-based Therapy Medicinal Product and Solutions
2.1.4 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene-based Therapy Medicinal Product and Solutions
2.2.4 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene-based Therapy Medicinal Product and Solutions
2.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene-based Therapy Medicinal Product and Solutions
2.6.4 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 Sunway Biotech
2.9.1 Sunway Biotech Details
2.9.2 Sunway Biotech Major Business
2.9.3 Sunway Biotech Gene-based Therapy Medicinal Product and Solutions
2.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sunway Biotech Recent Developments and Future Plans
2.10 SIBIONO
2.10.1 SIBIONO Details
2.10.2 SIBIONO Major Business
2.10.3 SIBIONO Gene-based Therapy Medicinal Product and Solutions
2.10.4 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SIBIONO Recent Developments and Future Plans
2.11 AnGes
2.11.1 AnGes Details
2.11.2 AnGes Major Business
2.11.3 AnGes Gene-based Therapy Medicinal Product and Solutions
2.11.4 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AnGes Recent Developments and Future Plans
2.12 Orchard Therapeutics
2.12.1 Orchard Therapeutics Details
2.12.2 Orchard Therapeutics Major Business
2.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Orchard Therapeutics Recent Developments and Future Plans
2.13 Human Stem Cells Institute
2.13.1 Human Stem Cells Institute Details
2.13.2 Human Stem Cells Institute Major Business
2.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product and Solutions
2.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Human Stem Cells Institute Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene-based Therapy Medicinal Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Gene-based Therapy Medicinal by Company Revenue
3.2.2 Top 3 Gene-based Therapy Medicinal Players Market Share in 2022
3.2.3 Top 6 Gene-based Therapy Medicinal Players Market Share in 2022
3.3 Gene-based Therapy Medicinal Market: Overall Company Footprint Analysis
3.3.1 Gene-based Therapy Medicinal Market: Region Footprint
3.3.2 Gene-based Therapy Medicinal Market: Company Product Type Footprint
3.3.3 Gene-based Therapy Medicinal Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene-based Therapy Medicinal Consumption Value and Market Share by Type (2018-2023)
4.2 Global Gene-based Therapy Medicinal Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2023)
5.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
6.2 North America Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
6.3 North America Gene-based Therapy Medicinal Market Size by Country
6.3.1 North America Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
6.3.2 United States Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
6.3.3 Canada Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
6.3.4 Mexico Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
7.2 Europe Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
7.3 Europe Gene-based Therapy Medicinal Market Size by Country
7.3.1 Europe Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
7.3.2 Germany Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.3 France Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.5 Russia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.6 Italy Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Gene-based Therapy Medicinal Market Size by Region
8.3.1 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2018-2029)
8.3.2 China Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.3 Japan Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.4 South Korea Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.5 India Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.7 Australia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
9.2 South America Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
9.3 South America Gene-based Therapy Medicinal Market Size by Country
9.3.1 South America Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
9.3.2 Brazil Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
9.3.3 Argentina Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Country
10.3.1 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
10.3.2 Turkey Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10.3.4 UAE Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Gene-based Therapy Medicinal Market Drivers
11.2 Gene-based Therapy Medicinal Market Restraints
11.3 Gene-based Therapy Medicinal Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene-based Therapy Medicinal Industry Chain
12.2 Gene-based Therapy Medicinal Upstream Analysis
12.3 Gene-based Therapy Medicinal Midstream Analysis
12.4 Gene-based Therapy Medicinal Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Gene-based Therapy Medicinal
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gene-based Therapy Medicinal by Type
1.3.1 Overview: Global Gene-based Therapy Medicinal Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Gene-based Therapy Medicinal Consumption Value Market Share by Type in 2022
1.3.3 Viral Gene Delivery System
1.3.4 Non-viral Gene Delivery System
1.4 Global Gene-based Therapy Medicinal Market by Application
1.4.1 Overview: Global Gene-based Therapy Medicinal Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Neurological Diseases
1.4.3 Cancer
1.4.4 Other
1.5 Global Gene-based Therapy Medicinal Market Size & Forecast
1.6 Global Gene-based Therapy Medicinal Market Size and Forecast by Region
1.6.1 Global Gene-based Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Gene-based Therapy Medicinal Market Size by Region, (2018-2029)
1.6.3 North America Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.4 Europe Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.6 South America Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Gene-based Therapy Medicinal Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene-based Therapy Medicinal Product and Solutions
2.1.4 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene-based Therapy Medicinal Product and Solutions
2.2.4 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene-based Therapy Medicinal Product and Solutions
2.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene-based Therapy Medicinal Product and Solutions
2.6.4 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 Sunway Biotech
2.9.1 Sunway Biotech Details
2.9.2 Sunway Biotech Major Business
2.9.3 Sunway Biotech Gene-based Therapy Medicinal Product and Solutions
2.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sunway Biotech Recent Developments and Future Plans
2.10 SIBIONO
2.10.1 SIBIONO Details
2.10.2 SIBIONO Major Business
2.10.3 SIBIONO Gene-based Therapy Medicinal Product and Solutions
2.10.4 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SIBIONO Recent Developments and Future Plans
2.11 AnGes
2.11.1 AnGes Details
2.11.2 AnGes Major Business
2.11.3 AnGes Gene-based Therapy Medicinal Product and Solutions
2.11.4 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AnGes Recent Developments and Future Plans
2.12 Orchard Therapeutics
2.12.1 Orchard Therapeutics Details
2.12.2 Orchard Therapeutics Major Business
2.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product and Solutions
2.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Orchard Therapeutics Recent Developments and Future Plans
2.13 Human Stem Cells Institute
2.13.1 Human Stem Cells Institute Details
2.13.2 Human Stem Cells Institute Major Business
2.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product and Solutions
2.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Human Stem Cells Institute Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene-based Therapy Medicinal Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Gene-based Therapy Medicinal by Company Revenue
3.2.2 Top 3 Gene-based Therapy Medicinal Players Market Share in 2022
3.2.3 Top 6 Gene-based Therapy Medicinal Players Market Share in 2022
3.3 Gene-based Therapy Medicinal Market: Overall Company Footprint Analysis
3.3.1 Gene-based Therapy Medicinal Market: Region Footprint
3.3.2 Gene-based Therapy Medicinal Market: Company Product Type Footprint
3.3.3 Gene-based Therapy Medicinal Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene-based Therapy Medicinal Consumption Value and Market Share by Type (2018-2023)
4.2 Global Gene-based Therapy Medicinal Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2023)
5.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
6.2 North America Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
6.3 North America Gene-based Therapy Medicinal Market Size by Country
6.3.1 North America Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
6.3.2 United States Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
6.3.3 Canada Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
6.3.4 Mexico Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
7.2 Europe Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
7.3 Europe Gene-based Therapy Medicinal Market Size by Country
7.3.1 Europe Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
7.3.2 Germany Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.3 France Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.5 Russia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
7.3.6 Italy Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Gene-based Therapy Medicinal Market Size by Region
8.3.1 Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2018-2029)
8.3.2 China Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.3 Japan Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.4 South Korea Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.5 India Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
8.3.7 Australia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
9.2 South America Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
9.3 South America Gene-based Therapy Medicinal Market Size by Country
9.3.1 South America Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
9.3.2 Brazil Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
9.3.3 Argentina Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Gene-based Therapy Medicinal Market Size by Country
10.3.1 Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2018-2029)
10.3.2 Turkey Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
10.3.4 UAE Gene-based Therapy Medicinal Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Gene-based Therapy Medicinal Market Drivers
11.2 Gene-based Therapy Medicinal Market Restraints
11.3 Gene-based Therapy Medicinal Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gene-based Therapy Medicinal Industry Chain
12.2 Gene-based Therapy Medicinal Upstream Analysis
12.3 Gene-based Therapy Medicinal Midstream Analysis
12.4 Gene-based Therapy Medicinal Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gene-based Therapy Medicinal Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Gene-based Therapy Medicinal Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biogen Company Information, Head Office, and Major Competitors
Table 6. Biogen Major Business
Table 7. Biogen Gene-based Therapy Medicinal Product and Solutions
Table 8. Biogen Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biogen Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene-based Therapy Medicinal Product and Solutions
Table 13. Novartis Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Gene-based Therapy Medicinal Product and Solutions
Table 18. Gilead Sciences Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Gilead Sciences Recent Developments and Future Plans
Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Sarepta Therapeutics Major Business
Table 22. Sarepta Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 23. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sarepta Therapeutics Recent Developments and Future Plans
Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Alnylam Pharmaceuticals Major Business
Table 27. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Solutions
Table 28. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 30. Amgen Company Information, Head Office, and Major Competitors
Table 31. Amgen Major Business
Table 32. Amgen Gene-based Therapy Medicinal Product and Solutions
Table 33. Amgen Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Amgen Recent Developments and Future Plans
Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Spark Therapeutics Major Business
Table 37. Spark Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 38. Spark Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Spark Therapeutics Recent Developments and Future Plans
Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Akcea Therapeutics Major Business
Table 42. Akcea Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 43. Akcea Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Akcea Therapeutics Recent Developments and Future Plans
Table 45. Sunway Biotech Company Information, Head Office, and Major Competitors
Table 46. Sunway Biotech Major Business
Table 47. Sunway Biotech Gene-based Therapy Medicinal Product and Solutions
Table 48. Sunway Biotech Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sunway Biotech Recent Developments and Future Plans
Table 50. SIBIONO Company Information, Head Office, and Major Competitors
Table 51. SIBIONO Major Business
Table 52. SIBIONO Gene-based Therapy Medicinal Product and Solutions
Table 53. SIBIONO Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. SIBIONO Recent Developments and Future Plans
Table 55. AnGes Company Information, Head Office, and Major Competitors
Table 56. AnGes Major Business
Table 57. AnGes Gene-based Therapy Medicinal Product and Solutions
Table 58. AnGes Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AnGes Recent Developments and Future Plans
Table 60. Orchard Therapeutics Company Information, Head Office, and Major Competitors
Table 61. Orchard Therapeutics Major Business
Table 62. Orchard Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 63. Orchard Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Orchard Therapeutics Recent Developments and Future Plans
Table 65. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
Table 66. Human Stem Cells Institute Major Business
Table 67. Human Stem Cells Institute Gene-based Therapy Medicinal Product and Solutions
Table 68. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Human Stem Cells Institute Recent Developments and Future Plans
Table 70. Global Gene-based Therapy Medicinal Revenue (USD Million) by Players (2018-2023)
Table 71. Global Gene-based Therapy Medicinal Revenue Share by Players (2018-2023)
Table 72. Breakdown of Gene-based Therapy Medicinal by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Gene-based Therapy Medicinal, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Gene-based Therapy Medicinal Players
Table 75. Gene-based Therapy Medicinal Market: Company Product Type Footprint
Table 76. Gene-based Therapy Medicinal Market: Company Product Application Footprint
Table 77. Gene-based Therapy Medicinal New Market Entrants and Barriers to Market Entry
Table 78. Gene-based Therapy Medicinal Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Gene-based Therapy Medicinal Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Gene-based Therapy Medicinal Consumption Value Share by Type (2018-2023)
Table 81. Global Gene-based Therapy Medicinal Consumption Value Forecast by Type (2024-2029)
Table 82. Global Gene-based Therapy Medicinal Consumption Value by Application (2018-2023)
Table 83. Global Gene-based Therapy Medicinal Consumption Value Forecast by Application (2024-2029)
Table 84. North America Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Gene-based Therapy Medicinal Raw Material
Table 115. Key Suppliers of Gene-based Therapy Medicinal Raw Materials
Table 1. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gene-based Therapy Medicinal Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Gene-based Therapy Medicinal Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biogen Company Information, Head Office, and Major Competitors
Table 6. Biogen Major Business
Table 7. Biogen Gene-based Therapy Medicinal Product and Solutions
Table 8. Biogen Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biogen Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene-based Therapy Medicinal Product and Solutions
Table 13. Novartis Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 16. Gilead Sciences Major Business
Table 17. Gilead Sciences Gene-based Therapy Medicinal Product and Solutions
Table 18. Gilead Sciences Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Gilead Sciences Recent Developments and Future Plans
Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 21. Sarepta Therapeutics Major Business
Table 22. Sarepta Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 23. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sarepta Therapeutics Recent Developments and Future Plans
Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Alnylam Pharmaceuticals Major Business
Table 27. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Solutions
Table 28. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 30. Amgen Company Information, Head Office, and Major Competitors
Table 31. Amgen Major Business
Table 32. Amgen Gene-based Therapy Medicinal Product and Solutions
Table 33. Amgen Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Amgen Recent Developments and Future Plans
Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Spark Therapeutics Major Business
Table 37. Spark Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 38. Spark Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Spark Therapeutics Recent Developments and Future Plans
Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Akcea Therapeutics Major Business
Table 42. Akcea Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 43. Akcea Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Akcea Therapeutics Recent Developments and Future Plans
Table 45. Sunway Biotech Company Information, Head Office, and Major Competitors
Table 46. Sunway Biotech Major Business
Table 47. Sunway Biotech Gene-based Therapy Medicinal Product and Solutions
Table 48. Sunway Biotech Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sunway Biotech Recent Developments and Future Plans
Table 50. SIBIONO Company Information, Head Office, and Major Competitors
Table 51. SIBIONO Major Business
Table 52. SIBIONO Gene-based Therapy Medicinal Product and Solutions
Table 53. SIBIONO Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. SIBIONO Recent Developments and Future Plans
Table 55. AnGes Company Information, Head Office, and Major Competitors
Table 56. AnGes Major Business
Table 57. AnGes Gene-based Therapy Medicinal Product and Solutions
Table 58. AnGes Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. AnGes Recent Developments and Future Plans
Table 60. Orchard Therapeutics Company Information, Head Office, and Major Competitors
Table 61. Orchard Therapeutics Major Business
Table 62. Orchard Therapeutics Gene-based Therapy Medicinal Product and Solutions
Table 63. Orchard Therapeutics Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Orchard Therapeutics Recent Developments and Future Plans
Table 65. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
Table 66. Human Stem Cells Institute Major Business
Table 67. Human Stem Cells Institute Gene-based Therapy Medicinal Product and Solutions
Table 68. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Human Stem Cells Institute Recent Developments and Future Plans
Table 70. Global Gene-based Therapy Medicinal Revenue (USD Million) by Players (2018-2023)
Table 71. Global Gene-based Therapy Medicinal Revenue Share by Players (2018-2023)
Table 72. Breakdown of Gene-based Therapy Medicinal by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Gene-based Therapy Medicinal, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Gene-based Therapy Medicinal Players
Table 75. Gene-based Therapy Medicinal Market: Company Product Type Footprint
Table 76. Gene-based Therapy Medicinal Market: Company Product Application Footprint
Table 77. Gene-based Therapy Medicinal New Market Entrants and Barriers to Market Entry
Table 78. Gene-based Therapy Medicinal Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Gene-based Therapy Medicinal Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Gene-based Therapy Medicinal Consumption Value Share by Type (2018-2023)
Table 81. Global Gene-based Therapy Medicinal Consumption Value Forecast by Type (2024-2029)
Table 82. Global Gene-based Therapy Medicinal Consumption Value by Application (2018-2023)
Table 83. Global Gene-based Therapy Medicinal Consumption Value Forecast by Application (2024-2029)
Table 84. North America Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Gene-based Therapy Medicinal Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Gene-based Therapy Medicinal Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Gene-based Therapy Medicinal Raw Material
Table 115. Key Suppliers of Gene-based Therapy Medicinal Raw Materials
LIST OF FIGURES
Figure 1. Gene-based Therapy Medicinal Picture
Figure 2. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gene-based Therapy Medicinal Consumption Value Market Share by Type in 2022
Figure 4. Viral Gene Delivery System
Figure 5. Non-viral Gene Delivery System
Figure 6. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Gene-based Therapy Medicinal Consumption Value Market Share by Application in 2022
Figure 8. Neurological Diseases Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global Gene-based Therapy Medicinal Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Gene-based Therapy Medicinal Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Gene-based Therapy Medicinal Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Gene-based Therapy Medicinal Consumption Value Market Share by Region in 2022
Figure 16. North America Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Gene-based Therapy Medicinal Revenue Share by Players in 2022
Figure 22. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Gene-based Therapy Medicinal Market Share in 2022
Figure 24. Global Top 6 Players Gene-based Therapy Medicinal Market Share in 2022
Figure 25. Global Gene-based Therapy Medicinal Consumption Value Share by Type (2018-2023)
Figure 26. Global Gene-based Therapy Medicinal Market Share Forecast by Type (2024-2029)
Figure 27. Global Gene-based Therapy Medicinal Consumption Value Share by Application (2018-2023)
Figure 28. Global Gene-based Therapy Medicinal Market Share Forecast by Application (2024-2029)
Figure 29. North America Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 39. France Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 46. China Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 49. India Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 63. Gene-based Therapy Medicinal Market Drivers
Figure 64. Gene-based Therapy Medicinal Market Restraints
Figure 65. Gene-based Therapy Medicinal Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Gene-based Therapy Medicinal in 2022
Figure 68. Manufacturing Process Analysis of Gene-based Therapy Medicinal
Figure 69. Gene-based Therapy Medicinal Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Gene-based Therapy Medicinal Picture
Figure 2. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gene-based Therapy Medicinal Consumption Value Market Share by Type in 2022
Figure 4. Viral Gene Delivery System
Figure 5. Non-viral Gene Delivery System
Figure 6. Global Gene-based Therapy Medicinal Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Gene-based Therapy Medicinal Consumption Value Market Share by Application in 2022
Figure 8. Neurological Diseases Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global Gene-based Therapy Medicinal Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Gene-based Therapy Medicinal Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Gene-based Therapy Medicinal Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Gene-based Therapy Medicinal Consumption Value Market Share by Region in 2022
Figure 16. North America Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Gene-based Therapy Medicinal Revenue Share by Players in 2022
Figure 22. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Gene-based Therapy Medicinal Market Share in 2022
Figure 24. Global Top 6 Players Gene-based Therapy Medicinal Market Share in 2022
Figure 25. Global Gene-based Therapy Medicinal Consumption Value Share by Type (2018-2023)
Figure 26. Global Gene-based Therapy Medicinal Market Share Forecast by Type (2024-2029)
Figure 27. Global Gene-based Therapy Medicinal Consumption Value Share by Application (2018-2023)
Figure 28. Global Gene-based Therapy Medicinal Market Share Forecast by Application (2024-2029)
Figure 29. North America Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 39. France Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 46. China Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 49. India Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Gene-based Therapy Medicinal Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 63. Gene-based Therapy Medicinal Market Drivers
Figure 64. Gene-based Therapy Medicinal Market Restraints
Figure 65. Gene-based Therapy Medicinal Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Gene-based Therapy Medicinal in 2022
Figure 68. Manufacturing Process Analysis of Gene-based Therapy Medicinal
Figure 69. Gene-based Therapy Medicinal Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
